Cm. Bamberger et al., GLUCOCORTICOID RECEPTOR-BETA, A POTENTIAL ENDOGENOUS INHIBITOR OF GLUCOCORTICOID ACTION IN HUMANS, The Journal of clinical investigation, 95(6), 1995, pp. 2435-2441
Alternative splicing of the human glucocorticoid receptor (hGR) pre-mR
NA generates two highly homologous isoforms, termed hGR alpha and hGR
beta. hGR alpha is a ligand-activated transcription factor which, in t
he hormone-bound state, modulates the expression of glucocorticoid-res
ponsive genes by binding to specific glucocorticoid response element (
GRE) DNA sequences, In contrast, hGR beta does not bind glucocorticoid
s and is transcriptionally inactive, We demonstrate here that hGR beta
is able to inhibit the effects of hormone-activated hGR alpha on a gl
ucocorticoid-responsive reporter gene in a concentration-dependent man
ner. [H-3]-Dexamethasone binding studies indicate that hGR beta does n
ot alter the affinity of hGR alpha for its hormonal ligand, The presen
ce of hGR beta in nuclear extracts and its ability to bind to a radiol
abeled GRE oligonucleotide suggest that its inhibitory effect may be d
ue to competition for GRE target sites, Reverse transcription-PCR anal
ysis shows expression of hGR beta mRNA in multiple human tissues, Thes
e results indicate that hGR beta may be a physiologically and pathophy
siologically relevant endogenous inhibitor of glucocorticoid action, w
hich may participate in defining the sensitivity of target tissues to
glucocorticoids, They also underline the importance of distinguishing
between the two receptor isoforms in all future studies of hGR functio
n and the need to revisit old data,